DE602005017409D1 - Assoziation von proteinpolymorphismen mit koronarer herzkrankheit - Google Patents

Assoziation von proteinpolymorphismen mit koronarer herzkrankheit

Info

Publication number
DE602005017409D1
DE602005017409D1 DE602005017409T DE602005017409T DE602005017409D1 DE 602005017409 D1 DE602005017409 D1 DE 602005017409D1 DE 602005017409 T DE602005017409 T DE 602005017409T DE 602005017409 T DE602005017409 T DE 602005017409T DE 602005017409 D1 DE602005017409 D1 DE 602005017409D1
Authority
DE
Germany
Prior art keywords
heart disease
coronary heart
association
protein polymorphisms
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017409T
Other languages
English (en)
Inventor
Detlef Kozian
Heinz Goegelein
Karl-Ernst Siegler
Martina Jacobs
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of DE602005017409D1 publication Critical patent/DE602005017409D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602005017409T 2004-09-10 2005-08-27 Assoziation von proteinpolymorphismen mit koronarer herzkrankheit Active DE602005017409D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04021528A EP1637612A1 (de) 2004-09-10 2004-09-10 Verband von Protein Polymorfismen zu Herzkrankheit
PCT/EP2005/009270 WO2006027128A1 (en) 2004-09-10 2005-08-27 Association of protein polymorphisms with coronary heart disease

Publications (1)

Publication Number Publication Date
DE602005017409D1 true DE602005017409D1 (de) 2009-12-10

Family

ID=34926489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017409T Active DE602005017409D1 (de) 2004-09-10 2005-08-27 Assoziation von proteinpolymorphismen mit koronarer herzkrankheit

Country Status (15)

Country Link
US (1) US20070292859A1 (de)
EP (2) EP1637612A1 (de)
JP (1) JP5376802B2 (de)
KR (1) KR101232100B1 (de)
CN (1) CN101018873B (de)
AT (1) ATE447045T1 (de)
AU (1) AU2005281927B2 (de)
BR (1) BRPI0515346A (de)
CA (1) CA2579885C (de)
DE (1) DE602005017409D1 (de)
DK (1) DK1791976T3 (de)
HK (1) HK1107709A1 (de)
IL (2) IL181554A (de)
MX (1) MX2007002589A (de)
WO (1) WO2006027128A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9365899B2 (en) * 2007-04-26 2016-06-14 The Regents Of The University Of Michigan FIG4 gene mutations in neurodegeneration
US10907217B1 (en) * 2015-09-01 2021-02-02 Creighton University High resolution melt-curve analysis to identify the sequence type of E. coli

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US6027884A (en) * 1993-06-17 2000-02-22 The Research Foundation Of The State University Of New York Thermodynamics, design, and use of nucleic acid sequences
JP3661953B2 (ja) * 1995-09-18 2005-06-22 進 清野 新規なａｔｐ感受性のカリウムチャネル蛋白質とその遺伝子
GB9523497D0 (en) * 1995-11-16 1996-01-17 Ashcroft Frances Cell membrane protein and application thereof
WO2003031935A2 (en) * 2001-10-11 2003-04-17 Genacy System, method, and apparatus for disease susceptibility testing
WO2004018701A2 (en) * 2002-08-22 2004-03-04 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof

Also Published As

Publication number Publication date
DK1791976T3 (da) 2010-03-08
MX2007002589A (es) 2007-08-06
EP1791976A1 (de) 2007-06-06
IL211178A0 (en) 2011-04-28
US20070292859A1 (en) 2007-12-20
KR20070050473A (ko) 2007-05-15
KR101232100B1 (ko) 2013-02-12
CA2579885A1 (en) 2006-03-16
BRPI0515346A (pt) 2008-07-22
EP1637612A1 (de) 2006-03-22
ATE447045T1 (de) 2009-11-15
JP2008512103A (ja) 2008-04-24
IL181554A (en) 2012-05-31
IL211178A (en) 2012-08-30
AU2005281927A1 (en) 2006-03-16
CA2579885C (en) 2014-05-06
EP1791976B1 (de) 2009-10-28
IL181554A0 (en) 2007-07-04
HK1107709A1 (en) 2008-04-11
CN101018873B (zh) 2011-11-02
JP5376802B2 (ja) 2013-12-25
CN101018873A (zh) 2007-08-15
AU2005281927B2 (en) 2011-12-01
WO2006027128A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
DE60323231D1 (de) Verkürzte tau proteine
CY1108829T1 (el) Ενεργοποιηση ace2 για θεραπεια καρδιακης, πνευμονικης και νεφρικης ασθενειας και υπερτασης
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
EP2287618A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
ATE408841T1 (de) Assay zum nachweis von glykiertem oder glykosyliertem hämoglobin (hba1c)
WO2002082075A3 (de) Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien
AR056125A1 (es) Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
ATE447045T1 (de) Assoziation von proteinpolymorphismen mit koronarer herzkrankheit
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
EP1560025A3 (de) Marker spezifisch für Diabetes
DE69836333D1 (de) Neisseria lactoferrin-bindendes protein
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
ATE360094T1 (de) Tcf-1 nukleotidsequenzvariation
WO2003082897A3 (en) Synthetic active peptide fragments
ATE481498T1 (de) Verfahren zur messung von neprilysinaktivität
WO2003020911A3 (en) Human schizophrenia gene
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
DE60023460D1 (de) Cdna von menschlicher methylentetrahydrofolatreduktase
WO2006075187A3 (en) Animals exhibiting an altered preference for an addictive substance
WO2003076950A3 (de) Screeningverfahren zum identifizieren protektiver substanzen für die behandlung neurodegenerativer und/oder ischämischer erkrankungen
DE50310939D1 (de) Verfahren zur bestimmung des allelischen zustandes am 5'-ende des alpha-s1-kaseingens
HUP0203080A2 (hu) A PRV-1 gén és felhasználása
WO2004074446A3 (en) Parkin interacting polypeptides and methods of use
WO2000056922A3 (en) Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof
AU2003240449A1 (en) Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition